Invictus RG’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-2,283
Closed -$378K – 680
2017
Q1
$378K Buy
+2,283
New +$363K 0.25% 136
2016
Q3
– Sell
-1,013
Closed -$133K – 692
2016
Q2
$133K Buy
1,013
+782
+339% +$107K 0.14% 246
2016
Q1
$32K Sell
231
-980
-81% -$131K 0.04% 384
2015
Q4
$169K Buy
+1,211
New +$167K 0.16% 228

Other funds holding ELV

Invictus RG's ELV Position: Q2 2017 in Review

Invictus RG sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 2,283 shares — an estimated $378K sold.

Invictus RG first reported a position in ELV in Q4 2015 and held it in 4 quarters. The position peaked at $378K in Q1 2017. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Invictus RG reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • Invictus RG sold 2,283 Elevance Health shares in Q2 2017, an estimated $378K.
  • Invictus RG first reported a position in Elevance Health in Q4 2015 and held it in 4 quarters.
  • Invictus RG's Elevance Health position peaked at $378K in Q1 2017.
  • 852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Invictus RG's 13F filing for Q2 2017, filed 14 Aug 2017.